ABBVIE STEMCENTRX LLC
40Patents
40Active
40Granted
55Portfolio score
Filing activity: Sep 2, 2011 → Jun 22, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10035853B2 | Site-specific antibody conjugation methods and compositions | Chemistry; Metallurgy | 8 | Active |
| US9931420B2 | Methods of making DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9931421B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9770518B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9855343B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9861708B2 | Kits containing DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9878053B2 | Methods of delivering DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9937268B2 | Anti-DLL3 antibody drug conjugates and methods of use | Physics | 7 | Active |
| US9480757B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9867887B1 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9486537B2 | Anti-DLL3 antibody drug conjugates | Physics | 7 | Active |
| US9775916B1 | Anti-DLL3 antibody drug conjugates for treating cancer | Physics | 7 | Active |
| US9764042B1 | Methods of making DLL3 antibody drug conjugates | Physics | 7 | Active |
| US10308721B2 | Anti-DLL3 antibodies and drug conjugates for use in melanoma | Physics | 6 | Active |
| US10137204B2 | Anti-DLL3 antibody drug conjugates for treating cancer | Physics | 6 | Active |
| US9676850B2 | Anti SEZ6 antibodies and methods of use | Chemistry; Metallurgy | 6 | Active |
| US9534058B2 | Anti-CD324 monoclonal antibodies and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US10478509B2 | Anti-DLL3 antibody drug conjugates for treating cancer | Chemistry; Metallurgy | 5 | Active |
| US11033634B2 | Light chain variable regions | Physics | 5 | Active |
| US10053511B2 | Anti-claudin antibodies and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9481727B2 | Anti-DLL3 antibody drug conjugates | Physics | 2 | Active |
| US9968687B2 | Anti-DLL3 antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US10047163B2 | Multispecific constructs | Chemistry; Metallurgy | 2 | Active |
| US9993566B2 | SEZ6 modulators and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9777071B2 | Anti-DPEP3 antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.